Zdrowie i gospodarka · 26/01/2018
FDA Announces Draft Guidance for Developing Fixed-Dose Combination Drugs for Hypertension Treatment
The US Food and Drug Administration (FDA) has released a draft guidance to help pharmaceutical companies develop fixed-dose combination drugs for treating high blood pressure, focusing on two-drug combinations of previously approved medications.